No Data
No Data
Express News | AIM ImmunoTech : Independent Board Members to Receive 100% of Director Compensation in Aim Stock
AIM ImmunoTech Announces Cash Conservation Plan
Kellner Group Isses Letter to Stockholders of AIM ImmunoTech
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
Insider Purchase: CEO & President of $AIM (AIM) Buys 60,110 Shares
Express News | AIM ImmunoTech Form4 Filing Shows CEO And President Thomas K Equels Bought 60,110 Shares At An Average Price Of $0.18/Share
No Data
No Data